Ushbu ish iqtibos qilgan ishlar

171 ta ish

Ish: Exploring cellular immunotherapy platforms in multiple myeloma

Gene editing for immune cell therapies
Stefanie R. Bailey, Marcela V. Maus
Sharh maqola20192 iqtibos
ABI
Insight into mechanisms associated with cytokine release syndrome and neurotoxicity after CD19 CAR-T cell immunotherapy
Cassie Chou, Cameron J. Turtle
Sharh maqola20192 iqtibos
ABI
How to Train Your T Cells: Overcoming Immune Dysfunction in Multiple Myeloma
Adam D. Cohen, Noopur Raje, Jessica Fowler +3
Sharh maqola20192 iqtibos
ABI
Potent anti-myeloma efficacy of dendritic cell therapy in combination with pomalidomide and programmed death-ligand 1 blockade in a preclinical model of multiple myeloma
Tan-Huy Chu, Manh-Cuong Vo, Hye-Seong Park +4
Maqola20202 iqtibos
ABI
Lisocabtagene maraleucel for patients with relapsed or refractory large B-cell lymphomas (TRANSCEND NHL 001): a multicentre seamless design study
Jeremy S Abramson, M. Lia Palomba, Leo I. Gordon +19
Maqola20202 iqtibos
ABI
Neoadjuvant anti-OX40 (MEDI6469) therapy in patients with head and neck squamous cell carcinoma activates and expands antigen-specific tumor-infiltrating T cells
Rebekka Duhen, Carmen Ballesteros‐Merino, Alexandra K. Frye +12
Maqola20212 iqtibos
ABI
Synthetic TILs: Engineered Tumor-Infiltrating Lymphocytes With Improved Therapeutic Potential
Anaïs Jiménez-Reinoso, Daniel Nehme-Álvarez, Carmen Domínguez-Alonso +1
Sharh maqola20212 iqtibos
ABI
CAR T-cell therapy in multiple myeloma: more room for improvement
Phaik Ju Teoh, Wee Joo Chng
Sharh maqola20212 iqtibos
ABI
Individualized genetic makeup that controls natural killer cell function influences the efficacy of isatuximab immunotherapy in patients with multiple myeloma
Haibo Sun, Thomas G. Martin, John Donald Marra +7
Maqola20212 iqtibos
ABI
The Cancer-Immunity Cycle in Multiple Myeloma
Mika Casey, Kyohei Nakamura
Sharh maqola20212 iqtibos
ABI
Expansion of cytotoxic natural killer cells in multiple myeloma patients using K562 cells expressing OX40 ligand and membrane-bound IL-18 and IL-21
Jaya Lakshmi Thangaraj, Minh‐Trang Thi Phan, SoonHo Kweon +14
Maqola20212 iqtibos
ABI
NKG2D-CAR-transduced natural killer cells efficiently target multiple myeloma
Alejandra Leivas, Antonio Valeri, Laura Córdoba +15
Maqola20212 iqtibos
ABI
CXCR4 and anti-BCMA CAR co-modified natural killer cells suppress multiple myeloma progression in a xenograft mouse model
Yu Yang Ng, Zhicheng Du, Xi Zhang +2
Maqola20212 iqtibos
ABI
Autologous NK cells as consolidation therapy following stem cell transplantation in multiple myeloma
Hareth Nahi, Michael Chrobok, Stephan Meinke +20
Maqola20222 iqtibos
ABI
Two for one: targeting BCMA and CD19 in B-cell malignancies with off-the-shelf dual-CAR NK-92 cells
Gils Roex, Diana Campillo-Davó, Donovan Flumens +6
Maqola20222 iqtibos
ABI
Novel IL-15 dendritic cells have a potent immunomodulatory effect in immunotherapy of multiple myeloma
Tan-Huy Chu, Manh-Cuong Vo, Jaya Lakshmi Thangaraj +8
Maqola20222 iqtibos
ABI
Natural killer cells have a synergistic anti-tumor effect in combination with chemoradiotherapy against head and neck cancer
Eun Kyung Jung, Tan-Huy Chu, Manh-Cuong Vo +10
Maqola20222 iqtibos
ABI
Preclinical and clinical studies of CAR-NK-cell therapies for malignancies
Hongwen Li, Wenting Song, Zhaoming Li +1
Sharh maqola20222 iqtibos
ABI
Expanded natural killer cells potentiate the antimyeloma activity of daratumumab, lenalidomide, and dexamethasone in a myeloma xenograft model
Jaya Lakshmi Thangaraj, Sung‐Hoon Jung, Manh-Cuong Vo +11
Maqola20222 iqtibos
ABI
FT555: Off-the-Shelf CAR-NK Cell Therapy Co-Targeting GPRC5D and CD38 for the Treatment of Multiple Myeloma
John Reiser, Szeman Ruby Chan, Ketan Mathavan +16
Maqola20222 iqtibos
ABI
Allogeneic CAR-NK Cell Therapy Targeting Both BCMA and GPRC5D for the Treatment of Multiple Myeloma
Zhuoxiao Cao, Cuiqing Yang, Yifang Wang +9
Maqola20222 iqtibos
ABI
Anti-BCMA-CAR NK Cells Expressing Soluble TRAIL: Promising Therapeutic Approach for Multiple Myeloma in Combination with Bortezomib and γ-Secretase Inhibitors
Benjamin Motais, Sandra Charvátová, Matouš Hrdinka +2
Maqola20222 iqtibos
ABI
Research progress of neoantigen-based dendritic cell vaccines in pancreatic cancer
Xin Zhang, Zheng Xu, Xiangpeng Dai +2
Sharh maqola20232 iqtibos
ABI
Targeting B Cell Maturation Antigen in Patients with Multiple Myeloma: Current Perspectives
Trilok Shrivastava, Frits van Rhee, Samer Al Hadidi
Sharh maqola20232 iqtibos
ABI
Sarlavhasiz
Boshqa2 iqtibos
ABI